Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
Clinical trial NCT07223814 · RECRUITING
Trial details
- NCT number
- NCT07223814
- Sponsor
- Stichting Hemato-Oncologie voor Volwassenen Nederland
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2030-06-01
- Enrollment
- 875
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.